Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Penghai Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Shijiazhuang, Hebei, China. Established in 2006, the company focuses on the production of large-volume parenterals (LVP), including intravenous solutions in various packaging formats such as polypropylene bottles and multi-layer co-extrusion bags. Its core product portfolio includes Magnesium Sulfate sterile solutions and Metronidazole Sodium Chloride injections, catering to indications like electrolyte imbalance and systemic infections. The company operates GMP-certified facilities and has been recognized as a high-tech enterprise in Hebei province. While it was formerly listed on the National Equities Exchange and Quotations (NEEQ), it currently operates as a private joint-stock company. In addition to its commercial portfolio, the company conducts clinical research through its subsidiary, Shijiazhuang Xingze Pharmaceutical Technology, exploring new applications for its sterile solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Penghai Pharmaceutical.